Having a part of his spleen removed and a rare chronic disease hasn’t stopped 12-year-old E’Shon Guy from living a normal ...

Family members have called for an independent investigation into CaSandra Pearson's death, saying she belonged in a hospital ...

Daniel Cressy's illness was a barrier to getting his pilot's license, until a novel treatment was approved in the United ...

Sickle cell disease remains a major public health challenge in India, particularly among tribal populations. According to ...

A Nashville doctor helped pioneer an FDA approved "state-of-the-art" gene-editing therapy that could be a cure for painful ...

The first person to ever be cured of sickle cell anemia in Louisiana received revolutionary gene therapy. The treatment is now offered at this hospital.

This deals another blow to tebapivat’s development prospects following its May 2026 termination in MDS due to efficacy ...

Zydus Lifesciences has received permission to conduct a Phase III clinical trial of Desidustat for patients with sickle cell disease. Conducted in collaboration with the Indian Council of Medical ...

Agios Pharma has said it will halt clinical development of tebapivat, a PK activator that had reached phase 2 testing in ...

Gene editing has delivered remarkable results against sickle cell disease. Now researchers are working to make these personalized treatments faster, cheaper, and available to far more patients.

WOAI NBC News Channel 4 San Antonio provides local news, weather forecasts, traffic updates, investigations, and items of ...

A phase 2 study of Agios Pharmaceuticals’ next-generation pyruvate kinase (PK) activator has failed to support continued development in sickle cell disease (SCD), leading the co ...